Scientific Background
PT-141 (Bremelanotide) is a melanocortin-receptor agonist studied for its effects on libido, arousal, and sexual-response pathways in both sexes.
Mechanism of Action (Informational Only)

• MC3R/MC4R receptor activation
• Influences arousal pathways in the CNS
• Does not rely on vascular pathways

Potential Functional Benefits

• Popular in sexual-wellness research
• Supports libido-enhancement models
• Works for both male and female research subjects

Vial Contents

• 10mg PT-141

Notes
Research use only.